Skip to content

Perioperative Hyperoxia vs Normoxia Biomarker Trial

Effects of Perioperative Hyperoxia Versus Normoxia on Pulmonary, Endothelial, and Inflammatory Biomarkers in Elective Laparoscopic Lower Abdominal Surgery

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07525661
Enrollment
76
Registered
2026-04-13
Start date
2017-07-01
Completion date
2019-02-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Glycocalyx Injury, Hyperoxia, Oxidative Stress, Perioperative Care

Keywords

Hyperoxia, Normoxia, Perioperative Oxygen Therapy, Syndecan-1, Sialic Acid, Surfactant Protein-A, TNF-alpha, Randomized Trial

Brief summary

This single-center randomized interventional study evaluated the biological effects of two perioperative oxygen strategies in adults undergoing elective laparoscopic lower abdominal surgery under standardized general anesthesia. Participants were assigned to receive either normoxia (FiO2 0.35) or hyperoxia (FiO2 0.80) after intubation and throughout the intraoperative period. The study assessed perioperative changes in circulating biomarkers related to pulmonary epithelial stress, endothelial glycocalyx injury, oxidative stress, and inflammation, together with blood gas and hemodynamic parameters. The study was completed before registration and is being registered retrospectively.

Detailed description

Perioperative oxygen administration is widely used during general anesthesia, but the biological effects of liberal oxygen exposure remain uncertain. This randomized parallel-group study compared a normoxic strategy (FiO2 0.35) with a hyperoxic strategy (FiO2 0.80) in adult patients undergoing elective laparoscopic lower abdominal surgery. The assigned inspired oxygen fraction was initiated immediately after tracheal intubation and maintained intraoperatively under volume-controlled ventilation with otherwise standardized anesthetic management. The primary objective was to compare perioperative changes in circulating biomarkers reflecting endothelial glycocalyx injury and inflammatory activation. Biomarkers assessed included syndecan-1, sialic acid, surfactant protein-A, ischemia-modified albumin, tumor necrosis factor-alpha, and total protein. Secondary assessments included arterial and venous blood gas variables, lactate, mean arterial pressure, and heart rate. This study was completed before registry submission and is being entered retrospectively for transparency.

Interventions

OTHERPerioperative Oxygen Strategy - Normoxia

Normoxia arm: FiO2 0.35 Intervention started immediately after intubation and maintained intraoperatively

OTHERPerioperative Oxygen Strategy-Hyperoxia

Hyperoxia arm: FiO2 0.80 Intervention started immediately after intubation and maintained intraoperatively

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 to 70 years * Scheduled for elective laparoscopic lower abdominal surgery * Expected surgery duration of at least 90 minutes * ASA physical status I to III * Body mass index 18.5 to 35 kg/m2 * Planned management under standardized general anesthesia with volume-controlled ventilation

Exclusion criteria

* Known chronic pulmonary disease, including chronic obstructive pulmonary disease or asthma requiring regular medication * Baseline peripheral oxygen saturation below 92% on room air * Significant cardiovascular instability * Severe hepatic or renal dysfunction * Active infection or systemic inflammatory disease * Use of systemic corticosteroids or immunosuppressive therapy * Pregnancy * Inability to provide informed consent * Anticipated difficult airway * Expected need for postoperative mechanical ventilation

Design outcomes

Primary

MeasureTime frameDescription
Concentration of syndecan-110 minutes after establishment of assigned oxygen fraction and immediately after surgery/post-extubationSerum syndecan-1 concentration measured in duplicate.
Concentration of sialic acid10 minutes after establishment of assigned oxygen fraction and immediately after surgery/post-extubationSerum sialic acid concentration measured in duplicate.
Concentration of surfactant protein-A10 minutes after establishment of assigned oxygen fraction and immediately after surgery/post-extubationSerum surfactant protein-A concentration measured in duplicate.
Concentration of ischemia-modified albumin10 minutes after establishment of assigned oxygen fraction and immediately after surgery/post-extubationSerum ischemia-modified albumin concentration measured in duplicate.
Concentration of TNF-alpha10 minutes after establishment of assigned oxygen fraction and immediately after surgery/post-extubationSerum TNF-alpha concentration measured in duplicate.
Concentration of total protein10 minutes after establishment of assigned oxygen fraction and immediately after surgery/post-extubationSerum total protein concentration measured in duplicate.

Secondary

MeasureTime frameDescription
Arterial oxygen tension (PaO2)10 minutes after establishment of assigned oxygen fraction
Intraoperative mean arterial pressureImmediately after intubation and every 15 minutes up to 90 minutes
Intraoperative heart rateImmediately after intubation and every 15 minutes up to 90 minutes
Arterial pH10 minutes after establishment of assigned oxygen fractionArterial pH measured on blood gas analysis.
Arterial carbon dioxide tension (PaCO2)10 minutes after establishment of assigned oxygen fractionArterial partial pressure of carbon dioxide.
Venous oxygen tension (PvO2)10 minutes after establishment of assigned oxygen fractionVenous partial pressure of oxygen.
Venous carbon dioxide tension (PvCO2)10 minutes after establishment of assigned oxygen fractionVenous partial pressure of carbon dioxide.
Arterial oxygen saturation (SaO2)10 minutes after establishment of assigned oxygen fractionArterial oxygen saturation measured on blood gas analysis.
Venous oxygen saturation (SvO2)10 minutes after establishment of assigned oxygen fractionVenous oxygen saturation measured on blood gas analysis.
Arteriovenous oxygen difference10 minutes after establishment of assigned oxygen fractionDifference between arterial and venous oxygen saturation.
Lactate concentration10 minutes after establishment of assigned oxygen fractionBlood lactate concentration measured on blood gas analysis.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026